Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Analysis of the Blood Signature of the Microbiota as a Diagnostic Marker of Alzheimer's Disease in the Early Stages of the Process: Pilot Study
Authors not listed
University Hospital, Montpellier · 2021
Abstract
This study aims to validate a difference in blood microbial signature between Alzheimer's patients and control subjects in order to propose potential innovative strategies
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Anonymous. (2021). Analysis of the Blood Signature of the Microbiota as a Diagnostic Marker of Alzheimer's Disease in the Early Stages of the Process: Pilot Study. <em>University Hospital, Montpellier</em>. https://clinicaltrials.gov/study/NCT04841135
Vancouver
Anonymous. Analysis of the Blood Signature of the Microbiota as a Diagnostic Marker of Alzheimer's Disease in the Early Stages of the Process: Pilot Study. University Hospital, Montpellier. 2021.
BibTeX
@misc{anon2021Analys,
title = {Analysis of the Blood Signature of the Microbiota as a Diagnostic Marker of Alzheimer's Disease in the Early Stages of the Process: Pilot Study},
author = {Anonymous},
journal = {University Hospital, Montpellier},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of California, Davis 2022
Open access · US-GOV
Proof of Mechanism Study of Senicapoc in Mild or Prodromal Alzheimer's Disease
Inmune Bio, Inc. 2022
Open access · US-GOV
A Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Guangzhou University of Traditional Chinese Medicine 2021
Open access · US-GOV
Exploring Research on Early Warning Indicators of Protein in Patients With Mild Cognitive Impairment and Alzheimer's Disease
Beijing Friendship Hospital 2015
Open access · US-GOV
Monetary Cost of Alzheimer's Disease in China: Study Protocol for a Cluster Randomized Observational Study
Storz Medical AG 2015
Open access · US-GOV
Transcranial Pulse Stimulation for Alzheimer's Disease in an Open Prospective Pilot Study
Samus Therapeutics, Inc. 2016
Open access · US-GOV